Medical Event Reporting (10 CFR 35.3045)

Introduction

A medical event is not a synonym for patient harm — it is a regulatory definition. Under 10 CFR 35.3045, the U.S. Nuclear Regulatory Commission specifies exact dose and percentage thresholds, plus categories such as wrong-patient and wrong-radiopharmaceutical administrations and leaking sealed sources, that obligate a licensee to notify the NRC, the referring physician, and the patient on a strict timeline.¹ Many medical events cause no observable injury; some clinically meaningful errors never meet the regulatory threshold. The two ideas overlap, but they are not the same — and confusing them is one of the most common sources of trouble for a nuclear medicine program.

For a radiation safety officer (RSO) and authorized users, three things must be second nature: knowing precisely what triggers a medical event, knowing the notification clock the moment one is discovered, and — most importantly — building a written-directive and verification workflow that prevents them in the first place. A medical event is reportable regardless of intent, and the reporting timeline is unforgiving, so the work is front-loaded into prevention.¹²

This guide explains the regulatory definition, walks through the dose and percentage thresholds with worked math, lays out the notification timeline, and describes the written-directive controls that stop most events before they happen. It complements our guides to the radiation safety officer role and the distinction between sentinel events and serious reportable events. DRPS supports this work as part of radiation safety officer consulting and radioactive material license support across Florida, Maryland, Virginia, Washington DC, California, and Nevada.

Topic Explanation

What is a medical event?

A medical event is a defined regulatory occurrence under 10 CFR 35.3045 in which an administration of byproduct material — or radiation from byproduct material — departs materially from the written directive, involves a fundamental administration error, or involves a leaking sealed source above limits.¹ It exists so that the NRC can track, analyze, and where necessary respond to administrations that fall outside the intended plan, independent of whether the patient experienced a clinical effect.

The key conceptual point is that the definition is built on objective thresholds and categories, not clinical judgment about outcome. This is intentional: it produces a consistent, auditable trigger that does not depend on whether a particular patient happened to be harmed. The RSO's job is to recognize when those objective triggers are met and to act on the reporting obligation immediately.¹²

This regulatory framing distinguishes the NRC medical event from hospital-side concepts like sentinel events. A single incident can be both, one, or neither, and the reporting pathways are separate — a point developed in our comparison of sentinel events versus serious reportable events.

The categories that trigger a medical event

Under 10 CFR 35.3045, a medical event generally arises in the following situations, subject to the dose thresholds described below:¹

The delivered dose or activity differs from the written directive by more than the specified dose and percentage thresholds.
The wrong radiopharmaceutical or radioactive drug is administered.
The dose is delivered to the wrong individual or wrong treatment site.
The dose is delivered by the wrong route of administration.
The dose differs from the prescribed dose or dose that would have resulted from the written directive such that specified limits are exceeded.
A sealed source used in therapy leaks, or a source is lost, in a manner producing the specified dose consequences.

Each of these is evaluated against the dose magnitude criteria in the rule, which is what separates a reportable medical event from a minor, non-reportable deviation.¹

Key Technical Principles

The dose and percentage thresholds

The medical-event definition combines an absolute dose criterion with a relative percentage criterion. In broad terms, a medical event occurs when a delivered dose differs from the written-directive intent such that:¹

the total effective dose equivalent (EDE) differs by ≥ 0.05 Sv (5 rem), or
the dose to an organ, tissue, or the skin differs by ≥ 0.5 Sv (50 rem),

and the difference between the delivered and prescribed dose meets a relative criterion — typically that the delivered dose differs from the prescribed dose by ≥ 20%, or falls outside a prescribed dose range, depending on the specific paragraph of the rule.¹ Wrong-patient, wrong-drug, wrong-route, and wrong-site administrations become medical events when they produce doses at or above those same absolute levels.

The dual requirement matters: a deviation that is large in percentage but tiny in absolute dose may not be reportable, and a large absolute dose that is within the prescribed plan is not a deviation at all. Both arms of the test must be satisfied. Because the exact wording, paragraph structure, and any updates govern, the current regulatory text must always be consulted for a real case.

Trigger category	Absolute dose criterion	Relative criterion	Typical examples
Dose deviation from written directive	EDE ≥ 0.05 Sv or organ/skin ≥ 0.5 Sv	Differs from prescribed by ≥ 20% (or outside prescribed range)	Therapy activity error; fractionation error
Wrong radiopharmaceutical	Resulting dose at the above levels	Administration not per written directive	Wrong therapy agent dispensed
Wrong individual or wrong site	Resulting dose at the above levels	Not the intended patient/site	Patient-identification failure
Wrong route of administration	Resulting dose at the above levels	Route differs from directive	Intended IV given by another route
Leaking or lost sealed source	Specified dose consequence	n/a (event-based)	Therapy source leakage

The table summarizes the structure of the rule for orientation; it is not a substitute for the regulatory text, which controls in any real determination.¹

A worked dose-deviation example

Consider a therapy in which the written directive prescribes an organ-absorbed dose of $D_{p} = 2.0 Sv$ to the target tissue. Because of an activity error, the delivered organ dose is $D_{d} = 2.6 Sv$ . Evaluate both arms of the test.

Absolute difference:

Δ D = ∣ D_{d} - D_{p} ∣ = ∣2.6 - 2.0∣ = 0.6 Sv

Since $0.6 Sv \geq 0.5 Sv$ , the organ-dose absolute criterion is met.

Relative difference:

% deviation = \frac{∣ D _{d} - D _{p} ∣}{D _{p}} \times 100% = \frac{0.6}{2.0} \times 100% = 30%

Since $30% \geq 20%$ , the relative criterion is also met. Both arms are satisfied, so this is a medical event and the reporting obligations are triggered.¹

Now suppose instead the delivered dose were $D_{d} = 2.3 Sv$ :

Δ D = 0.3 Sv (< 0.5 Sv), % deviation = \frac{0.3}{2.0} \times 100% = 15% (< 20%)

Here neither the absolute organ-dose criterion nor the 20% relative criterion is met, so under this paragraph the deviation would not be a medical event — though it should still be investigated internally as a quality and ALARA concern. The arithmetic is simple; the discipline is in performing it promptly and against the correct prescribed quantity.¹²

The notification clock

Once a medical event is identified, 10 CFR 35.3045 imposes a strict, multi-channel notification timeline:¹

Discovery \to \leq next calendar day NRC Operations Center by phone \to \leq 15 days Written report

In parallel, the referring physician and the patient (or a responsible relative or guardian) must generally be notified no later than 24 hours after discovery, unless the referring physician personally informs the licensee that they will provide the notification or that, based on medical judgment, telling the patient would be harmful — and even then specific documentation rules apply.¹ In Agreement States, the telephone notification goes to the state radiation-control agency rather than the NRC Operations Center.

Clinical Impact

Therapy carries the highest stakes

Medical events most often draw scrutiny in therapeutic contexts — radiopharmaceutical therapy and certain implant or sealed-source treatments — because that is where doses are high enough to cross the absolute thresholds. An I-131 therapy activity error, a wrong-patient administration, or an infiltrated therapeutic injection can all become reportable events with real clinical weight. Published reviews of accidental and unintended exposures in nuclear medicine consistently identify administration and identification errors as recurring root causes.³⁴ For the dosimetry side of modern therapy, see Lu-177 theranostics dosimetry and the RPT shielding guide.

The reputational and regulatory cost

Beyond the dose to the patient, a medical event triggers regulatory engagement, potential inspection, and entry into the NRC's event tracking. A pattern of events, or a single event handled poorly, can affect license standing. The cost of a robust prevention program is far lower than the cost of recurring events and the regulatory attention they attract.²⁵

Patient trust

The 24-hour patient-notification expectation means a facility must be prepared to communicate clearly and compassionately about an event, often before the full investigation is complete. Facilities that have a communication plan in advance handle these conversations far better than those improvising under time pressure.¹⁴

Practical Optimization Tips

1. Make the written directive bulletproof

For administrations requiring a written directive, 10 CFR 35.40 specifies what the directive must contain, and 10 CFR 35.41 requires written procedures to verify that each administration matches it.⁶⁷ The directive must be dated and signed before administration (with narrow provisions for oral revisions properly documented). A complete, legible, pre-administration written directive is the foundation everything else rests on.

2. Build a time-out and double-check

Borrow from surgical safety: a formal pre-administration "time-out" that independently verifies patient identity (two identifiers), radiopharmaceutical, activity, route, and site against the written directive catches the wrong-patient and wrong-drug errors that dominate medical-event causes.³⁴ Independent double-checks of activity measurement and decay correction guard the dose-deviation arm.

3. Standardize activity measurement and decay correction

Many dose-deviation events trace to dose-calibrator measurement or decay-correction mistakes. Rigorous dose calibrator quality control and a standardized decay-correction worksheet reduce the arithmetic errors that push delivered activity past the 20% threshold.

4. Pre-write the notification playbook

Keep a current one-page playbook: who declares an event, the NRC Operations Center phone number (or the Agreement State contact), the next-calendar-day phone deadline, the 15-day written-report deadline, the 24-hour patient/physician notification, and who drafts each. When the clock is running, a checklist beats memory.¹

5. Investigate near-misses, not just events

A deviation that lands at 15% today is a 25% event waiting to happen. Treat sub-threshold deviations and near-misses as data: trend them, find the systemic cause, and fix the workflow. This is the same ALARA-minded continuous-improvement posture described in occupational exposure monitoring.

Common pitfalls to avoid

Equating medical event with patient harm. They are different concepts; report based on the regulatory definition.
Missing the next-calendar-day phone call. The clock starts at discovery, not at the end of the investigation.
Comparing to the wrong baseline. Deviation is measured against the prescribed dose in the written directive.
Forgetting the patient/physician notification. The 24-hour channel is separate from the NRC channel.
Reporting to the wrong authority. Agreement State licensees notify the state, not the NRC Operations Center.
Treating prevention as paperwork. Time-outs and double-checks are what actually stop events.

Regulatory Considerations

Medical event reporting lives entirely within the NRC byproduct-material framework — it is not an X-ray-machine concept. It applies to medical use of radioactive material licensed under 10 CFR Part 35 (or an Agreement State equivalent), with dose limits and definitions anchored in 10 CFR Part 20.¹⁸⁹

Key provisions:

10 CFR 35.3045 — the medical-event definition, dose and percentage thresholds, and notification requirements.¹
10 CFR 35.3047 — separate reporting for dose to an embryo, fetus, or nursing child exceeding specified limits as a result of an administration to the mother.¹⁰ This is distinct from the 35.3045 medical-event categories and addresses a different scenario; for the imaging-dose side of fetal exposure, see fetal dose in medical imaging.
10 CFR 35.40 and 35.41 — written-directive content and the written procedures required to ensure administrations conform to it.⁶⁷
10 CFR Part 20 — the underlying radiation-protection standards and dose quantities.⁸
NRC NUREG-1556, Volume 9 — program-specific guidance for medical-use licensees, including expectations for procedures, the RSO, and reporting.⁹

Agreement States administer compatible programs, so the medical-event concept and thresholds are equivalent, but notification flows to the state radiation-control agency. Of the jurisdictions DRPS serves, Florida, Maryland, Virginia, California, and Nevada are Agreement States, while Washington DC is regulated directly by the NRC. Every licensee must confirm which authority issues its license and follow that agency's exact contacts and procedures.⁹ For the broader licensing context, see our NRC license guide and common radiation safety violations.

Frequently Asked Questions (FAQs)

What is a medical event under 10 CFR 35.3045?

A medical event is a regulatory category, not a clinical injury. It is triggered when an administration of byproduct material or radiation from byproduct material differs from what the written directive intended by specified dose and percentage thresholds, or involves the wrong patient, wrong radiopharmaceutical, wrong route, or wrong treatment site, or when a sealed source leaks above limits. Many medical events cause no observable patient harm, yet they still require reporting.

Does a medical event mean the patient was harmed?

No. The term is defined by regulatory thresholds for dose deviation and administration errors, not by clinical outcome. Some medical events involve no detectable harm, while some clinically significant errors may not meet the regulatory definition. The two concepts overlap but are not the same, and both deserve attention.

What are the dose thresholds that trigger a medical event?

Broadly, a medical event arises when the delivered dose differs from the prescribed dose such that the effective dose equivalent differs by at least 0.05 Sv (5 rem), or the dose to an organ, tissue, or skin differs by at least 0.5 Sv (50 rem), AND the difference exceeds 20 percent of the prescribed dose (or, for certain situations, falls outside the prescribed range). Wrong-patient, wrong-drug, and wrong-route administrations meeting these dose levels are also medical events. Always check the exact current regulatory text.

How quickly must a medical event be reported to the NRC?

The licensee must notify the NRC Operations Center by telephone no later than the next calendar day after discovery of the medical event, and submit a written report to the appropriate NRC office (or Agreement State) within 15 days. The referring physician and the patient (or responsible party) must generally be notified no later than 24 hours after discovery.

What is the role of the written directive in preventing medical events?

For therapy and certain other administrations, 10 CFR 35.40 requires a dated, signed written directive specifying the patient, radiopharmaceutical or radiation, activity or dose, and treatment details. 10 CFR 35.41 requires written procedures to ensure each administration matches the written directive. A robust written-directive and verification workflow is the single most effective barrier against medical events.

Are medical events handled differently in Agreement States?

Agreement States adopt compatible regulations, so the medical-event concept and thresholds are equivalent, but the reporting pathway differs: notification goes to the Agreement State radiation-control agency rather than the NRC. Facilities must confirm which authority licenses them and follow that agency's exact notification procedure and contacts.

What is the difference between 10 CFR 35.3045 and 35.3047?

Section 35.3045 covers medical events involving departures from the written directive and certain administration errors. Section 35.3047 separately addresses dose to an embryo, fetus, or a nursing child that exceeds specified limits as a result of an administration to the mother. Both carry reporting obligations, but they address different scenarios.

Key Takeaways

A medical event is a regulatory definition, not a measure of harm. It is triggered by objective dose and percentage thresholds and by fundamental administration errors.
Both arms of the dose test must be met: an absolute criterion (EDE ≥ 0.05 Sv or organ/skin ≥ 0.5 Sv) and a relative criterion (typically ≥ 20% deviation), per the specific paragraph of the rule.
The notification clock is strict: NRC Operations Center (or Agreement State) by phone no later than the next calendar day, written report within 15 days, and patient/referring-physician notification generally within 24 hours.
The written directive (35.40) and written procedures (35.41) are the core preventive controls, backed by time-outs, double identifiers, and independent dose checks.
Agreement States report to the state, not the NRC; confirm your licensing authority and contacts in advance.
Near-misses are prevention data. Trend sub-threshold deviations to fix systemic causes before they become events.

Conclusion

Medical event reporting under 10 CFR 35.3045 is a test of preparation. The thresholds are knowable, the timeline is fixed, and the prevention controls are well established — but all three must be in place before an event occurs, because the notification clock starts the moment one is discovered. A program that has internalized the definition, can do the dose-deviation arithmetic quickly and correctly, and has a pre-written notification playbook will handle a rare event calmly and compliantly.

More importantly, the same rigor that makes reporting smooth — bulletproof written directives, time-outs, independent verification, and disciplined dose measurement — is what keeps most events from ever happening. The RSO and medical physicist who treat 35.3045 as a prevention framework, not just a reporting rule, protect patients, staff, and the license at the same time.

How DRPS Can Help

Diagnostic Radiation Physics Services helps nuclear medicine and radiopharmaceutical-therapy programs build medical-event prevention and response into their radiation safety programs as part of radiation safety officer consulting, radioactive material license support, and medical physics consulting. This can include written-directive and verification workflow design, time-out and double-check procedures, dose-deviation evaluation tools, notification playbooks tailored to NRC or Agreement State requirements, near-miss trending, and staff training.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, and Nevada. The goal is simple: make the compliant pathway the default pathway, so a rare event is handled correctly and most events never occur.

Related Resources

References

U.S. Nuclear Regulatory Commission. 10 CFR 35.3045: Report and notification of a medical event. ecfr.gov
U.S. Nuclear Regulatory Commission. NUREG-1556, Volume 9, Revision 3: Consolidated Guidance About Materials Licenses — Program-Specific Guidance About Medical Use Licenses. nrc.gov
Marengo M, Martin CJ, Rubow S, et al. Radiation safety and accidental radiation exposures in nuclear medicine. Seminars in Nuclear Medicine. 2022;52(2):94-113. doi:10.1053/j.semnuclmed.2021.11.006. doi.org
Martin CJ, Marengo M, Vassileva J, et al. Guidance on prevention of unintended and accidental radiation exposures in nuclear medicine. Journal of Radiological Protection. 2019;39(3):665-695. doi:10.1088/1361-6498/ab19d8. doi.org
U.S. Nuclear Regulatory Commission. Nuclear Material Events Database (NMED) and Abnormal Occurrence reports to Congress. nrc.gov
U.S. Nuclear Regulatory Commission. 10 CFR 35.40: Written directives. ecfr.gov
U.S. Nuclear Regulatory Commission. 10 CFR 35.41: Procedures for administrations requiring a written directive. ecfr.gov
U.S. Nuclear Regulatory Commission. 10 CFR Part 20: Standards for Protection Against Radiation. ecfr.gov
U.S. Nuclear Regulatory Commission. 10 CFR Part 35: Medical Use of Byproduct Material. ecfr.gov
U.S. Nuclear Regulatory Commission. 10 CFR 35.3047: Report and notification of a dose to an embryo/fetus or a nursing child. ecfr.gov
International Commission on Radiological Protection. ICRP Publication 86: Prevention of Accidents to Patients Undergoing Radiation Therapy. Annals of the ICRP. 2000;30(3). icrp.org